Literature DB >> 7378086

Acetylator phenotype in idiopathic systemic lupus erythematosus.

M M Reidenberg, M Levy, D E Drayer, E Zylber-Katz, W C Robbins.   

Abstract

The acetylator phenotypes of 21 patients from New York City and 29 patients from Israel with idiopathic systemic lupus erythematosus (SLE) were determined with dapsone or isoniazid. Thirty were slwo acetylators, 17 were rapid, and 3 indeterminate. These cases plus published studies of acetylator phenotypes in idiopathic SLE show a worldwide distribution of 150 slow to 77 rapid instead of the expected 122:105 (P less than 0.001). The relationship between acetylator phenotype and possible etiologic agents is discussed.

Entities:  

Mesh:

Year:  1980        PMID: 7378086     DOI: 10.1002/art.1780230508

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 2.  Systemic lupus erythematosus clinical issues.

Authors:  M B Stevens
Journal:  Springer Semin Immunopathol       Date:  1986

3.  Hepatic acetylator phenotype in porphyria cutanea tarda.

Authors:  J M Ladero; R Enriquez de Salamanca; S Chinarro
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

Review 4.  Survey of the human acetylator polymorphism in spontaneous disorders.

Authors:  D A Evans
Journal:  J Med Genet       Date:  1984-08       Impact factor: 6.318

5.  Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes.

Authors:  C A McQueen; C J Maslansky; I B Glowinski; S B Crescenzi; W W Weber; G M Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

6.  Polymorphic acetylation: lack of influence of rheumatic disease activity and concomitant drug administration.

Authors:  C Astbury; C Beyeler; H A Bird
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

7.  Acetylation polymorphism and leprosy.

Authors:  L C Eze; A N Okpogba; A U Ogan
Journal:  Biochem Genet       Date:  1990-02       Impact factor: 1.890

Review 8.  The effect of chronic renal failure on drug metabolism and transport.

Authors:  Albert W Dreisbach; Juan J L Lertora
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-08       Impact factor: 4.481

Review 9.  Acetylator phenotype and lupus erythematosus.

Authors:  J P Uetrecht; R L Woosley
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

Review 10.  Genetically determined variability in acetylation and oxidation. Therapeutic implications.

Authors:  D W Clark
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.